Hyperphosphorylation and cleavage at D421 enhance tau secretion.

It is well established that tau pathology propagates in a predictable manner in Alzheimer's disease (AD). Moreover, tau accumulates in the cerebrospinal fluid (CSF) of AD's patients. The mechanisms underlying the propagation of tau pathology and its accumulation in the CSF remain to be elu...

Full description

Bibliographic Details
Main Authors: Vanessa Plouffe, Nguyen-Vi Mohamed, Jessica Rivest-McGraw, Johanne Bertrand, Michel Lauzon, Nicole Leclerc
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3352936?pdf=render
_version_ 1818270890335404032
author Vanessa Plouffe
Nguyen-Vi Mohamed
Jessica Rivest-McGraw
Johanne Bertrand
Michel Lauzon
Nicole Leclerc
author_facet Vanessa Plouffe
Nguyen-Vi Mohamed
Jessica Rivest-McGraw
Johanne Bertrand
Michel Lauzon
Nicole Leclerc
author_sort Vanessa Plouffe
collection DOAJ
description It is well established that tau pathology propagates in a predictable manner in Alzheimer's disease (AD). Moreover, tau accumulates in the cerebrospinal fluid (CSF) of AD's patients. The mechanisms underlying the propagation of tau pathology and its accumulation in the CSF remain to be elucidated. Recent studies have reported that human tau was secreted by neurons and non-neuronal cells when it was overexpressed indicating that tau secretion could contribute to the spreading of tau pathology in the brain and could lead to its accumulation in the CSF. In the present study, we showed that the overexpression of human tau resulted in its secretion by Hela cells. The main form of tau secreted by these cells was cleaved at the C-terminal. Surprisingly, secreted tau was dephosphorylated at several sites in comparison to intracellular tau which presented a strong immunoreactivity to all phospho-dependent antibodies tested. Our data also revealed that phosphorylation and cleavage of tau favored its secretion by Hela cells. Indeed, the mimicking of phosphorylation at 12 sites known to be phosphorylated in AD enhanced tau secretion. A mutant form of tau truncated at D421, the preferential cleavage site of caspase-3, was also significantly more secreted than wild-type tau. Taken together, our results indicate that hyperphosphorylation and cleavage of tau by favoring its secretion could contribute to the propagation of tau pathology in the brain and its accumulation in the CSF.
first_indexed 2024-12-12T21:17:28Z
format Article
id doaj.art-b45e93e0ccc849088cd3a00359c783f9
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T21:17:28Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-b45e93e0ccc849088cd3a00359c783f92022-12-22T00:11:42ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0175e3687310.1371/journal.pone.0036873Hyperphosphorylation and cleavage at D421 enhance tau secretion.Vanessa PlouffeNguyen-Vi MohamedJessica Rivest-McGrawJohanne BertrandMichel LauzonNicole LeclercIt is well established that tau pathology propagates in a predictable manner in Alzheimer's disease (AD). Moreover, tau accumulates in the cerebrospinal fluid (CSF) of AD's patients. The mechanisms underlying the propagation of tau pathology and its accumulation in the CSF remain to be elucidated. Recent studies have reported that human tau was secreted by neurons and non-neuronal cells when it was overexpressed indicating that tau secretion could contribute to the spreading of tau pathology in the brain and could lead to its accumulation in the CSF. In the present study, we showed that the overexpression of human tau resulted in its secretion by Hela cells. The main form of tau secreted by these cells was cleaved at the C-terminal. Surprisingly, secreted tau was dephosphorylated at several sites in comparison to intracellular tau which presented a strong immunoreactivity to all phospho-dependent antibodies tested. Our data also revealed that phosphorylation and cleavage of tau favored its secretion by Hela cells. Indeed, the mimicking of phosphorylation at 12 sites known to be phosphorylated in AD enhanced tau secretion. A mutant form of tau truncated at D421, the preferential cleavage site of caspase-3, was also significantly more secreted than wild-type tau. Taken together, our results indicate that hyperphosphorylation and cleavage of tau by favoring its secretion could contribute to the propagation of tau pathology in the brain and its accumulation in the CSF.http://europepmc.org/articles/PMC3352936?pdf=render
spellingShingle Vanessa Plouffe
Nguyen-Vi Mohamed
Jessica Rivest-McGraw
Johanne Bertrand
Michel Lauzon
Nicole Leclerc
Hyperphosphorylation and cleavage at D421 enhance tau secretion.
PLoS ONE
title Hyperphosphorylation and cleavage at D421 enhance tau secretion.
title_full Hyperphosphorylation and cleavage at D421 enhance tau secretion.
title_fullStr Hyperphosphorylation and cleavage at D421 enhance tau secretion.
title_full_unstemmed Hyperphosphorylation and cleavage at D421 enhance tau secretion.
title_short Hyperphosphorylation and cleavage at D421 enhance tau secretion.
title_sort hyperphosphorylation and cleavage at d421 enhance tau secretion
url http://europepmc.org/articles/PMC3352936?pdf=render
work_keys_str_mv AT vanessaplouffe hyperphosphorylationandcleavageatd421enhancetausecretion
AT nguyenvimohamed hyperphosphorylationandcleavageatd421enhancetausecretion
AT jessicarivestmcgraw hyperphosphorylationandcleavageatd421enhancetausecretion
AT johannebertrand hyperphosphorylationandcleavageatd421enhancetausecretion
AT michellauzon hyperphosphorylationandcleavageatd421enhancetausecretion
AT nicoleleclerc hyperphosphorylationandcleavageatd421enhancetausecretion